AzTrials
AzTrials

StrokeNCT07603102

Mindfulness With Dual-Task Training in Post-Stroke Mild Cognitive Impairment

A study testing mindfulness, Dual-Task Training and Aerobic Training in people with Stroke and Mild Cognitive Impairment (MCI), run by Nanjing Mingzhou Rehabilitation Hospital at 1 site in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to investigate whether a combined intervention of mindfulness and dual-task training can improve cognitive function and physical performance in individuals with mild cognitive impairment after stroke. Read more about this study

Who is it for?
Ages 55 years and older
Conditions the study is for
Stroke, Mild Cognitive Impairment (MCI)
What is being tested?
mindfulness, Dual-Task Training and Aerobic Training
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteChina
Study dates
1 May 2026to Nov 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 55 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosis of stroke confirmed by computed tomography (CT) or magnetic resonance imaging (MRI).
  • Time since stroke onset ≥3 months and medically stable.
  • Presence of mild cognitive impairment after stroke, defined by a Montreal - - Montreal Cognitive Assessment (MoCA) score < 26.
  • Mini-Mental State Examination (MMSE) score ≥ 24.
  • Ability to walk independently with or without an assistive device for at least 10 meters.
  • Stable medication regimen for at least 4 weeks prior to enrollment.
  • Ability to understand study instructions and provide written informed consent.

Who cannot join

  • Severe aphasia, visual impairment, hearing impairment, or communication disorders that interfere with assessment or training participation.
  • Severe depression or other major psychiatric disorders.
  • Other neurological diseases affecting cognition or movement (e.g., Parkinson's disease, multiple sclerosis, traumatic brain injury).
  • Severe musculoskeletal, cardiovascular, or systemic diseases that contraindicate exercise participation.
  • Participation in other structured cognitive or rehabilitation intervention programs within the past 3 months.
  • Unstable medical condition or recurrent stroke during the study period.
  • Inability to safely complete the training protocol as determined by the study investigators.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Jingzhi Zhang contact

+86-16677137704

170787717@qq.com

China1 site, 1 recruiting
  • Nanjing Mingzhou Rehabilitation Hospital

    Nanjing

    Jingzhi Zhang, +86-16677137704, 170787717@qq.com

    Recruiting

Other trials in China

About this study

Official title: Mindfulness Combined With Dual-Task Training for Post-Stroke Mild Cognitive Impairment: A Randomized Controlled Trial

This study aims to investigate whether a combined intervention of mindfulness and dual-task training can improve cognitive function and physical performance in individuals with mild cognitive impairment after stroke.

Being tested
mindfulness, Dual-Task Training, Aerobic Training, Health education
Medical subject headings
Stroke, Cognitive Dysfunction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • mindfulnessOther

    Guided by a professional mindfulness instructor, participants engage in mindfulness meditation to enhance attention, emotional regulation, and cognitive readiness. The training includes breath awareness, body scan, and present-moment awareness, delivered through guided meditation.Other Name:

  • Dual-Task TrainingDevice

    Dual-task training is a rehabilitation approach that targets cognitive-motor integration by requiring participants to perform a motor task and a cognitive task simultaneously. Examples include walking while performing mental calculations, memory tasks, or reaction-based exercises. The training is progressively adjusted by increasing task difficulty and cognitive load to improve attention allocation, executive function, and dual-task performance in daily activities.

  • Aerobic TrainingDevice

    Dual-task training is a rehabilitation approach that targets cognitive-motor integration by requiring participants to perform a motor task and a cognitive task simultaneously. Examples include walking while performing mental calculations, memory tasks, or reaction-based exercises. The training is progressively adjusted by increasing task difficulty and cognitive load to improve attention allocation, executive function, and dual-task performance in daily activities.

  • Health educationOther

    Health education is a non-exercise control intervention designed to provide participants with knowledge related to post-stroke health management. Topics include stroke recovery, healthy lifestyle behaviors, nutrition, medication adherence, daily activity management, and psychological well-being. The intervention is delivered through structured educational sessions or instructional materials and does not include active physical or cognitive training components.

Study groups in NCT07603102
Study groupRoleWhat they receive
MDT groupExperimentalMindfulness + Dual-Task Training
Receives: Other: mindfulness; Device: Dual-Task Training
DT groupExperimentalDual-Task Training + Health Education
Receives: Device: Dual-Task Training; Other: Health education
AT groupExperimentalAerobic Training + Health Education
Receives: Device: Aerobic Training; Other: Health education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Montreal Cognitive Assessment (MoCA)

    The Montreal Cognitive Assessment (MoCA) is a widely used neuropsychological tool for detecting mild cognitive impairment (MCI). It assesses multiple cognitive domains, including attention, executive function, memory, language, visuospatial ability, abstraction, calculation, and orientation. The total score is 30 points, with higher scores indicating better cognitive function.

    Measured: From enrollment to the end of treatment at 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 May 2026
  2. Study start1 May 2026
  3. Primary completionNov 2026 (estimated)
  4. Study completionNov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07603102
Sponsor's protocol ID
NJKF202605002
Status last verified
May 2026
First submitted
16 May 2026
Last updated
22 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing mindfulness, Dual-Task Training and Aerobic Training in people with Stroke and Mild Cognitive Impairment (MCI), run by Nanjing Mingzhou Rehabilitation Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 22 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jingzhi Zhang (+86-16677137704, 170787717@qq.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Montreal Cognitive Assessment (MoCA) (time frame: From enrollment to the end of treatment at 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 May 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT07603102 | AzTrials